Common TitleNIAID SYNERGY (Genotype 1)
Official Title Virological Response after 6 Week Triple-Drug Regimens for Hepatitis C: a Proof-of-Concept Phase 2A Cohort Study
Phase Phase II
ClinicalTrials.gov NCT01805882
Treatments
Ledipasvir-Sofosbuvir
Ledipasvir-Sofosbuvir
Tradename:HarvoniOther Names:LDV-SOFClass:FDA-ApprovedFunding
Non-IndustryNational Institute of Allergy and Infectious Diseases (NIAID)